Validation analysis in datasets from patients with NB confirmed that BIRC5 mRNA was expressed at a significantly higher level in MYCN-amplified tumors (Figure 7D) and strongly predicted patient survival (Figure 7E). This evidence concerns the gene BIRC5 and neuroblastoma.